Sitagliptin - Another option for managing type 2 diabetes in dialysis patients?

Wendy L St Peter; Eric D Weinhandl; Michael F. Flessner

doi:10.1053/j.ajkd.2013.01.004

Sitagliptin - Another option for managing type 2 diabetes in dialysis patients?

Wendy L St Peter, Eric D Weinhandl, Michael F. Flessner

Pharmaceutical Care and Health Systems

Research output: Contribution to journal › Editorial › peer-review

8 Scopus citations

Original language	English (US)
Pages (from-to)	532-535
Number of pages	4
Journal	American Journal of Kidney Diseases
Volume	61
Issue number	4
DOIs	https://doi.org/10.1053/j.ajkd.2013.01.004
State	Published - Apr 2013

Bibliographical note

Funding Information:
Support: This work was supported by the Chronic Disease Research Group, Minneapolis Medical Research Foundation.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1053/j.ajkd.2013.01.004

OpenUrl availability

Full text

Cite this

@article{b4d6b3f26ac74274b6c1ced9e9be8e69,

title = "Sitagliptin - Another option for managing type 2 diabetes in dialysis patients?",

author = "{St Peter}, {Wendy L} and Weinhandl, {Eric D} and Flessner, {Michael F.}",

note = "Funding Information: Support: This work was supported by the Chronic Disease Research Group, Minneapolis Medical Research Foundation. ",

year = "2013",

month = apr,

doi = "10.1053/j.ajkd.2013.01.004",

language = "English (US)",

volume = "61",

pages = "532--535",

journal = "American Journal of Kidney Diseases",

issn = "0272-6386",